Clinical applications of optical coherence tomography in age-related macular degeneration

J. Fernando Arevalo; Reinaldo A. Garcia

doi:10.1007/978-0-387-68987-6_13

Clinical applications of optical coherence tomography in age-related macular degeneration

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Optical coherence tomography (OCT) is a noninvasive, dynamic technology ideal for observing the natural course of age-related macular degeneration (AMD). The structural information provided by OCT is becoming a valuable diagnostic adjunct to fluorescein angiography (FA) and indocyanine green videoangiography (ICGV). The goal of using OCT is to correlate these observed structural changes with changes in visual acuity (VA), not only to better understand the mechanism of vision loss associated with AMD, but also to understand the mechanism of VA benefits attributed to various treatments. In particular, OCT is a valuable tool to monitor the treatment effects associated with photodynamic therapy (PDT) as well as periocular and intraocular pharmacologic therapy in neovascular AMD.¹

Original language	English (US)
Title of host publication	Retinal Angiography and Optical Coherence Tomography
Publisher	Springer New York
Pages	253-265
Number of pages	13
ISBN (Print)	9780387689869
DOIs	https://doi.org/10.1007/978-0-387-68987-6_13
State	Published - Dec 1 2009
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-0-387-68987-6_13

Cite this

@inbook{52707255aee849ccaf5634e682ecd6d9,

title = "Clinical applications of optical coherence tomography in age-related macular degeneration",

abstract = "Optical coherence tomography (OCT) is a noninvasive, dynamic technology ideal for observing the natural course of age-related macular degeneration (AMD). The structural information provided by OCT is becoming a valuable diagnostic adjunct to fluorescein angiography (FA) and indocyanine green videoangiography (ICGV). The goal of using OCT is to correlate these observed structural changes with changes in visual acuity (VA), not only to better understand the mechanism of vision loss associated with AMD, but also to understand the mechanism of VA benefits attributed to various treatments. In particular, OCT is a valuable tool to monitor the treatment effects associated with photodynamic therapy (PDT) as well as periocular and intraocular pharmacologic therapy in neovascular AMD.1",

author = "Arevalo, {J. Fernando} and Garcia, {Reinaldo A.}",

year = "2009",

month = dec,

day = "1",

doi = "10.1007/978-0-387-68987-6_13",

language = "English (US)",

isbn = "9780387689869",

pages = "253--265",

booktitle = "Retinal Angiography and Optical Coherence Tomography",

publisher = "Springer New York",

}

TY - CHAP

T1 - Clinical applications of optical coherence tomography in age-related macular degeneration

AU - Arevalo, J. Fernando

AU - Garcia, Reinaldo A.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Optical coherence tomography (OCT) is a noninvasive, dynamic technology ideal for observing the natural course of age-related macular degeneration (AMD). The structural information provided by OCT is becoming a valuable diagnostic adjunct to fluorescein angiography (FA) and indocyanine green videoangiography (ICGV). The goal of using OCT is to correlate these observed structural changes with changes in visual acuity (VA), not only to better understand the mechanism of vision loss associated with AMD, but also to understand the mechanism of VA benefits attributed to various treatments. In particular, OCT is a valuable tool to monitor the treatment effects associated with photodynamic therapy (PDT) as well as periocular and intraocular pharmacologic therapy in neovascular AMD.1

AB - Optical coherence tomography (OCT) is a noninvasive, dynamic technology ideal for observing the natural course of age-related macular degeneration (AMD). The structural information provided by OCT is becoming a valuable diagnostic adjunct to fluorescein angiography (FA) and indocyanine green videoangiography (ICGV). The goal of using OCT is to correlate these observed structural changes with changes in visual acuity (VA), not only to better understand the mechanism of vision loss associated with AMD, but also to understand the mechanism of VA benefits attributed to various treatments. In particular, OCT is a valuable tool to monitor the treatment effects associated with photodynamic therapy (PDT) as well as periocular and intraocular pharmacologic therapy in neovascular AMD.1

UR - http://www.scopus.com/inward/record.url?scp=84892135304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892135304&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68987-6_13

DO - 10.1007/978-0-387-68987-6_13

M3 - Chapter

AN - SCOPUS:84892135304

SN - 9780387689869

SP - 253

EP - 265

BT - Retinal Angiography and Optical Coherence Tomography

PB - Springer New York

ER -

Clinical applications of optical coherence tomography in age-related macular degeneration

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this